Mail

Canada Markets closed

S&P/TSX
18,583.13
-395.88(-2.09%)
S&P 500
3,639.66
-104.86(-2.80%)
DOW
29,296.79
-630.15(-2.11%)
CAD/USD
0.7280
+0.0003(+0.0393%)
CRUDE OIL
93.04
+4.59(+5.19%)
BTC-CAD
26,853.38
-837.91(-3.03%)

STOCKS SLIDE, TREASURY YIELDS SPIKE AFTER U.S. JOBS DATA

Stronger-than-expected numbers dash hopes for a Federal Reserve rate hike pivot

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD

Add to watchlist

0.0500

+0.0100

(+25.00%)

At close: 10:33AM EDT

Currency in CAD

Valuation Measures⁴

Market Cap (intraday)	N/A
Enterprise Value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	N/A
Price/Book (mrq)	N/A
Enterprise Value/Revenue	N/A
Enterprise Value/EBITDA	N/A

Trading Information

Stock Price History

Beta (5Y Monthly)	0.56
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	0.1300
52 Week Low ³	0.0200
50-Day Moving Average ³	0.0566
200-Day Moving Average ³	0.0750

Share Statistics

Avg Vol (3 month) ³	52.55k
Avg Vol (10 day) ³	21.3k
Shares Outstanding ⁵	132.63M
Implied Shares Outstanding ⁶	N/A
Float ⁸	119.63M
% Held by Insiders ¹	14.66%
% Held by Institutions ¹	0.00%
Shares Short (Jul 14, 2022) ⁴	40.22k
Short Ratio (Jul 14, 2022) ⁴	4
Short % of Float (Jul 14, 2022) ⁴	N/A
Short % of Shares Outstanding (Jul 14, 2022) ⁴	0.03%
Shares Short (prior month Jun 14, 2022) ⁴	21.21k

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	N/A
Trailing Annual Dividend Yield ³	N/A
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 30, 2021
Most Recent Quarter (mrq)	Mar 30, 2022

Profitability

Profit Margin	-83.35%
Operating Margin (ttm)	-75.94%

Management Effectiveness

Return on Assets (ttm)	-29.86%
Return on Equity (ttm)	-144.05%

Income Statement

Revenue (ttm)	2.53M
Revenue Per Share (ttm)	0.02
Quarterly Revenue Growth (yoy)	-38.50%
Gross Profit (ttm)	2.69M
EBITDA	-1.91M
Net Income Avi to Common (ttm)	-2.1M
Diluted EPS (ttm)	-0.0110
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	2.28M
Total Cash Per Share (mrq)	0.02
Total Debt (mrq)	2.21M
Total Debt/Equity (mrq)	247.53
Current Ratio (mrq)	1.09
Book Value Per Share (mrq)	0.00

Cash Flow Statement

Operating Cash Flow (ttm)	-1.26M
Levered Free Cash Flow (ttm)	-706.9k